ES

Ezhil Santhi Sharanya Shre

Director Director DIN 07643408
DIN 07643408 First appointment Mar 2017 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Mar 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Ezhil Santhi Sharanya Shre

Data last updated:

Ezhil Santhi Sharanya Shre was a Director at Dr. V.R.E.Research Laboratories Private Limited (2017–2022). The company operates in Healthcare.

DIN 07643408
Primary Designation Director
Industry Healthcare
First Appointment 06 Mar 2017

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Mar 20172009₹45,225 (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dr. V.R.E.Research Laboratories Private Limited
Premium access

Shareholding and investment profile for Ezhil Santhi Sharanya Shre

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ezhil Santhi Sharanya Shre

Ezhil Santhi Sharanya Shre was first appointed on 06 Mar 2017 as Director at Dr. V.R.E.Research Laboratories Private Limited.

Ezhil Santhi Sharanya Shre held 1 earlier board appointment: Dr. V.R.E.Research Laboratories Private Limited (Director, 06 Mar 2017 to 09 Jul 2022).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available